AKTX

Akari Therapeutics
AKTX

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$1
279% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Ladenburg Thalmann
Ladenburg Thalmann
Aydin Huseynov
0% 1-yr AKTX win rate
5 Jan ‘26 15 days ago